Planned Parenthood Great Northwest, Hawai’i, Alaska, Indiana and Kentucky has begun offering an “advance provision” of abortion medication — a program called “Just In Case Abortion Pills” — at health centers in Washington state and Hawai’i. For the first time from a Planned Parenthood affiliate, patients can obtain mifepristone and misoprostol in advance to keep at home for potential future use to end an early pregnancy.
The initiative launched to respond to growing demand as public debate and legal challenges around abortion access prompt many people to seek options proactively. Rebecca Gibron, the affiliate’s president and CEO, said the expanding evidence for this model of care, together with supportive state policies in Washington and Hawai’i, made it the right time to offer the service.
Telehealth services and some online organizations have been prescribing abortion pills in advance for several years. Experts say the move by Planned Parenthood — an established, trusted provider with physical clinics as well as telehealth capacity — is notable because it makes advance provision available in person at 16 Planned Parenthood health centers across the two states, as well as through typical telehealth pathways.
Dr. Colleen McNicholas, the affiliate’s chief of medical affairs, emphasized that being the prescribing provider matters: patients who get pills and later decide to use them can return to the same clinical team for questions, evaluation of pregnancy dating, and follow-up care even if months have passed since the initial visit.
People in geographically isolated places, including many in Hawai’i and some parts of Washington, may find faster access to medication important because timing matters in early pregnancy. Researchers and clinicians note that mifepristone and misoprostol have a strong safety record when used together, and the World Health Organization includes guidance on self-managed use in the first trimester.
Anecdotal accounts suggest advance provision can simplify the experience. One person who asked to be identified only by a first name said she ordered pills from an international telemedicine group after the 2022 leak of the Supreme Court draft on Roe. When she later discovered she was pregnant, she used the medication immediately and described the experience as prompt and less traumatic than she had feared. The medications typically carry an expiration date of about two years, depending on the brand.
Planned Parenthood will charge $100 for the medication when added to another appointment, such as a well visit or STI screening, and $150 for a standalone visit, with financial assistance available for those who cannot afford it.
Legal and political context
The advance provision practice has drawn criticism from anti-abortion advocates who describe it as “stockpiling.” At a 2024 Senate hearing, Senator Cindy Hyde-Smith said she was alarmed that people could obtain abortion drugs without what she viewed as adequate doctor oversight. Then-FDA Commissioner Robert Califf responded that clinical discretion governs prescribing and that the FDA does not regulate the practice of medicine at the individual-provider level.
Most U.S. states allow patients to possess abortion pills; Louisiana is a notable exception after making the medications controlled substances in 2024. Broader access to mifepristone and telehealth prescribing has also been the subject of litigation — including a lawsuit brought by Louisiana seeking restrictions on the FDA’s rules that allow remote prescribing and mailing of the drug. The Supreme Court has temporarily left access unchanged while related cases proceed through the lower courts, but uncertainty remains.
Demand and outlook
Providers and advocates report an uptick in interest in advance provision after high-profile legal actions and court cases. Web traffic to informational sites and requests to providers have increased as people seek to secure options before potential policy changes.
Researchers caution that measuring how many people keep these medications on hand is difficult, but they say the idea is catching on, especially among residents of states with restrictive abortion laws. Cost, because most patients pay out of pocket rather than through insurance, can be a barrier in some cases.
Advocates for access point to international practice where these medicines are available over the counter in some countries and to WHO guidance supporting self-managed use in early pregnancy. They argue that making safe, effective medication more reachable — including through trusted providers with both telehealth and in-person services — can reduce delays, travel, and expense when people need to end an early pregnancy.
Planned Parenthood’s program is being watched as a potential model that could spread to other providers and states, even as legal challenges continue to shape the landscape for medication abortion in the U.S.